Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $8.49 Million - $35.2 Million
30,312,507 Added 2680.05%
31,443,550 $10.4 Million
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $400,786 - $631,427
378,100 Added 50.22%
1,131,043 $1.31 Million
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $741,132 - $1.05 Million
588,200 Added 357.04%
752,943 $1.27 Million
Q3 2023

Nov 14, 2023

SELL
$1.61 - $2.54 $120,428 - $189,992
-74,800 Reduced 31.23%
164,743 $298,000
Q2 2023

Aug 14, 2023

BUY
$1.14 - $1.95 $24,281 - $41,535
21,300 Added 9.76%
239,543 $445,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $166,920 - $304,629
139,100 Added 175.76%
218,243 $290,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $129,003 - $278,583
79,143 New
79,143 $133,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.